# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-16-033633
Filing Date
2016-06-10
Accepted
2016-06-10 07:12:58
Documents
4
Period of Report
2016-07-21
Effectiveness Date
2016-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | dffn20160607_def14a.htm | DEF 14A | 1097675
2 |  | proxypage2.jpg | GRAPHIC | 129563
3 |  | proxypage1.jpg | GRAPHIC | 301792
4 |  | a1.jpg | GRAPHIC | 27888
| Complete submission text file | 0001437749-16-033633.txt |  | 1727916

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24477 | Film No.: 161707363
SIC: 2834 Pharmaceutical Preparations